Drug Trial Radar · NCT06056297
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
176
Planned (sponsor's estimate)
Start
Jun 6, 2024
Primary completion
Sep 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- X4 PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Sep 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the efficacy and evaluate the safety and tolerability of mavorixafor in participants with congenital or acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections as assessed by demonstrating its clinical benefit and increasing levels of circulating neutrophils.
Conditions
- Neutropenia
Interventions
MavorixaforDrug
Mavorixafor will be administered per schedule specified in the arm description.
PlaceboDrug
Placebo will be administered per schedule specified in the arm description.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary Endpoint: Annualized Infection Rate Based on Infections Adjudicated by Blinded Infection Adjudication Committee (BIAC) During the Treatment PeriodTime frame: Up to 52 Weeks
- Co-primary Endpoint: Number of Participants Meeting the Definition of a Positive Absolute Neutrophil Count (ANC) ResponseTime frame: Up to 52 weeks
Locations
115 sites in 25 countries. Site status is shown where the registry gives one.
Phoenix Children's Hospital
Phoenix, Arizona · Recruiting
UC Irvine
Irvine, California · Recruiting
Orso Health
La Jolla, California · Recruiting
University of California, Los Angeles-UCLA
Los Angeles, California · Recruiting
Orso Health
Torrance, California · Withdrawn
GNP Research
Cooper City, Florida · Recruiting
University of Southern Florida
St. Petersburg, Florida · Recruiting
Children's Healthcare of Atlanta (CHOA)
Atlanta, Georgia · Recruiting
University of Iowa
Iowa City, Iowa · Recruiting
Boston Children's Cancer Center
Boston, Massachusetts · Recruiting
University of Michigan
Ann Arbor, Michigan · Recruiting
Washington University
St Louis, Missouri · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania · Recruiting
St. Jude Childrens; Research Hospital
Memphis, Tennessee · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
Cook Children's Medical Center
Fort Worth, Texas · Recruiting
Texas Children's Hospital/ Baylor College of Medicine
Houston, Texas · Recruiting
Sarah Cannon Research Institute
Woodland, Texas · Recruiting
University of Utah
Salt Lake City, Utah · Recruiting
Froedtert And Medical College Of Wisconsin
Milwaukee, Wisconsin · Recruiting
Hospital El Cruce
Buenos Aires, Argentina · Recruiting
Instituto de Investigaciones Clínicas Córdoba
Córdoba, Argentina · Recruiting
Santorio 9 de Julio
San Miguel de Tucumán, Argentina · Recruiting
Perth Children's Hospital
Nedlands, Australia · Recruiting
Icon Cancer Centre Southport
Southport, Australia · Recruiting
Ballarat Oncology And Haematology Services
Wendouree, Australia · Recruiting
Universitair Ziekenhuis Leuven
Leuven, Belgium · Recruiting
University of Alberta Hospital
Edmonton, Canada · Recruiting
BC Children's Hospital
Vancouver, Canada · Recruiting
Clinica IMBANACO S.A.S
Cali, Colombia · Recruiting
Clínica del Country
Chapinero, Colombia · Recruiting
Hospital Pablo Tobón Uribe
Medellín, Colombia · Recruiting
Fundacion Cardiovascular de Colombia-Instituto del Corazon Florida Blanca
Floridablanca, Santander Department, Colombia · Recruiting
The University Hospital Brno
Brno, Czechia · Withdrawn
Motol University Hospital
Prague, Czechia · Withdrawn
Institute of Hematology and Pediatric Oncology - Lyon
Lyon, France · Recruiting
Hôpital Saint Louis
Paris, France · Recruiting
Showing 40 of 115 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.